filmov
tv
Drugging the Elusive KRAS
Показать описание
American Association for Cancer Research
Рекомендации по теме
0:04:30
Drugging the Elusive KRAS
0:01:25
Drugging an undruggable pocket on KRAS
0:01:25
Challenges of KRAS-targeting for lung cancer therapy
0:27:16
Dr. Channing Der, Ph.D. presents about Targeting KRAS for Cancer Treatment
0:01:27
Advances in the development of KRAS inhibitors
0:04:46
We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer
0:04:01
What are the latest developments in KRAS-mutant NSCLC?
0:00:46
The beating heart of cancer (KRAS episode 1)
0:01:37
Treatment strategies for KRAS-mutant NSCLC with co-mutations
0:04:09
A New Era in Targeting KRAS
0:01:01
Targeting the Undruggable KRAS, 50 Years of Progress
0:01:09
Challenges in targeting KRASG12C mutations
0:01:42
Treating KRAS G12C Mutations
0:01:31
Optimizing and overcoming resistance to current KRAS inhibitors
0:01:12
Overcoming resistance to KRAS G12C inhibitors in NSCLC
0:11:25
Establishing a druggable target for KRAS driven cancers
1:01:44
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
0:00:57
KRAS The Beating Heart of Cancer
0:01:01
Efficacy of trametinib in patients with multiple myeloma with NRAS and KRAS mutations
1:18:54
Targeting KRAS G12C: Amgen's Breakthrough Treatment - Insights from I-Fen Chang and Terri Conne...
0:01:11
What is a KRAS mutation?
0:01:21
KRAS Binders Hidden in Nature
0:34:10
Daniel Ahn, D.O., M.S. discusses Targeting KRAS in Colorectal Cancer
0:16:40
AC20 - Global Research Update
0:04:30
0:01:25
0:01:25
0:27:16
0:01:27
0:04:46
0:04:01
0:00:46
0:01:37
0:04:09
0:01:01
0:01:09
0:01:42
0:01:31
0:01:12
0:11:25
1:01:44
0:00:57
0:01:01
1:18:54
0:01:11
0:01:21
0:34:10
0:16:40